Article
Why clinical trials matter — and what it takes to bring them to patients
Clinical trials are often described as the future of cancer care and, in many ways, they a...
Dr Adam Januszewski
MBBS AICSM AFMLM MRCP(Onc) PhD
GMC: 7020418Professional statement
Dr Adam Januszewski is a medical oncology consultant in central London with specialist expertise in lung cancer, immunotherapy, targeted therapy, clinical trials, chemotherapy, early-stage lung cancer and personalised medicine. He privately practises at Nuffield Health at St Bartholomew’s Hospital, while his NHS base is Barts Health NHS Trust, where he also serves as divisional lead for quality and safety at Barts Cancer Centre.
Dr Januszewski is a thoracic oncologist with a strong focus on patient-centred care and expanding access to innovative treatments through clinical research. He is the UK chief investigator for several international phase 2 and 3 trials and co-manages the clinical research delivery team at St Bartholomew’s Hospital. His academic background includes a PhD in genomic medicine from Imperial College London and a postgraduate diploma in cancer biology from The Institute of Cancer Research.
He is active in shaping national oncology services through his roles on the British Thoracic Oncology Group steering committee, the UK Lung Cancer Coalition and as a NICE technology appraiser. He also contributes to the development of national consent guidance with Cancer Research UK.
Dr Januszewski is committed to advancing personalised cancer treatment and ensuring patients have access to the latest therapies. He regularly presents at international conferences and contributes to scientific literature on lung cancer and precision oncology. He is a member of several professional bodies, including the Royal College of Physicians, European Society of Medical Oncology and the International Association for the Study of Lung Cancer.
Clinics
Central London, 38 Giltspur Street,Medical insurances accepted
Credentials
Professional experience
- 18 years of experience
- Medical oncology consultant, Barts Health NHS Trust
Subspecialties
- Early-stage lung cancer
Professional memberships
- International Association for the Study of Lung Cancer
- British Thoracic Oncology Group
Education
- PhD, Genome Sciences/Genomic, Imperial College London (2015 - 2019)
- PGDip, Oncology and Cancer Biology, The Institute of Cancer Research, University of London (2012 - 2014)
Positions in organisations
- Divisional Lead for Quality and Safety (Barts Cancer Centre)
- Co-Manager of the Clinical Research Deliver Team, St Bartholomew’s Hospital
Publications and conferences
- Georgia Hardavella, Dimitrios E. Magouliotis, Roberto Chalela, Adam Januszewski, Fabio Dennstaedt, Paul Martin Putora, Alfred So, Angshu Bhowmik. Breathe 2024 20: 230219; DOI: 10.1183/20734735.0219-2023
- McInnerney D, Quaife S, Cooke S, Michinson L, Pogson Z, Ricketts W, Januszewski A, Lerner A … Peak M, Nelson D (2024). Understanding the impact of distance and disadvantage on lung cancer are and outcomes: a study protocol. BMC Cancer 2;24(1):942
Languages spoken
- English
Registration number: 7020418
Content
Health content
Article
Liquid biopsies in lung cancer: A new era of faster, more personalised care
For people affected by lung cancer, understanding the disease’s biology is key to treatmen...
Article
Latest advances in lung cancer treatments
Lung cancer is a common and serious types of cancer. However, advances in diagnosis and tr...
Other information
Reviews
All reviews are from real patients and have been verified by our Customer Service department to ensure they meet our guidelines. Rules of the service
- Would you recommend this doctor?
- Treatment of the doctor
- Treatment of the staff
- Waiting time
- Condition of facilities
- I met to Dr. Adam Januszewski to discuss about my father for lung cancer. Doctor asked me to send me all the reports to study the case before consulting. By talking almost an hour he made each and everything crystal clear. Discussing all the points, answering my all the questions